This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
